当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Tolterodine Tartrate
DRUG FOR FURTHER PROCESSING
0093-7163
Teva Pharmaceuticals USA, Inc.
20201020
TOLTERODINE TARTRATE
DRUG FOR FURTHER PROCESSING
2
0093-7163_56678895-8d36-49f5-a3c0-8a94bd85d977
Tolterodine Tartrate
DRUG FOR FURTHER PROCESSING
0093-7164
Teva Pharmaceuticals USA, Inc.
20201020
TOLTERODINE TARTRATE
DRUG FOR FURTHER PROCESSING
4
0093-7164_56678895-8d36-49f5-a3c0-8a94bd85d977
Tiopronin
DRUG FOR FURTHER PROCESSING
0093-7909
Teva Pharmaceuticals USA, Inc.
20210702
TIOPRONIN
DRUG FOR FURTHER PROCESSING
100
0093-7909_843c104f-1f07-4112-b614-ee39e8351cc3
Glyburide
DRUG FOR FURTHER PROCESSING
0093-8034
Teva Pharmaceuticals USA, Inc.
20230727
GLYBURIDE
DRUG FOR FURTHER PROCESSING
1.5
0093-8034_0a2783a5-65c7-4187-9c81-70f73ff00752
Glyburide
DRUG FOR FURTHER PROCESSING
0093-8035
Teva Pharmaceuticals USA, Inc.
20230728
GLYBURIDE
DRUG FOR FURTHER PROCESSING
3
0093-8035_0a2783a5-65c7-4187-9c81-70f73ff00752
Glyburide
DRUG FOR FURTHER PROCESSING
0093-8036
Teva Pharmaceuticals USA, Inc.
20230622
GLYBURIDE
DRUG FOR FURTHER PROCESSING
6
0093-8036_0a2783a5-65c7-4187-9c81-70f73ff00752
Famciclovir
DRUG FOR FURTHER PROCESSING
0093-8117
Teva Pharmaceuticals USA, Inc.
20230623
FAMCICLOVIR
DRUG FOR FURTHER PROCESSING
125
0093-8117_c62597c7-f518-4229-9753-3509d9ccaa91
Famciclovir
DRUG FOR FURTHER PROCESSING
0093-8118
Teva Pharmaceuticals USA, Inc.
20230505
FAMCICLOVIR
DRUG FOR FURTHER PROCESSING
250
0093-8118_c62597c7-f518-4229-9753-3509d9ccaa91
Famciclovir
DRUG FOR FURTHER PROCESSING
0093-8119
Teva Pharmaceuticals USA, Inc.
20230505
FAMCICLOVIR
DRUG FOR FURTHER PROCESSING
500
0093-8119_c62597c7-f518-4229-9753-3509d9ccaa91
Cimetidine
DRUG FOR FURTHER PROCESSING
0093-8192
Teva Pharmaceuticals USA, Inc.
20230330
CIMETIDINE
DRUG FOR FURTHER PROCESSING
300
0093-8192_af8b87e7-0327-4e15-af40-ca8e74d183e1
Cimetidine
DRUG FOR FURTHER PROCESSING
0093-8204
Teva Pharmaceuticals USA, Inc.
20230330
CIMETIDINE
DRUG FOR FURTHER PROCESSING
400
0093-8204_af8b87e7-0327-4e15-af40-ca8e74d183e1
Cimetidine
DRUG FOR FURTHER PROCESSING
0093-8305
Teva Pharmaceuticals USA, Inc.
20230330
CIMETIDINE
DRUG FOR FURTHER PROCESSING
800
0093-8305_af8b87e7-0327-4e15-af40-ca8e74d183e1
Mexiletine Hydrochloride
DRUG FOR FURTHER PROCESSING
0093-8739
Teva Pharmaceuticals USA, Inc.
20230330
MEXILETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
150
0093-8739_c65394df-caeb-4d3d-b01c-bc30a492c9ca
Mexiletine Hydrochloride
DRUG FOR FURTHER PROCESSING
0093-8740
Teva Pharmaceuticals USA, Inc.
20230330
MEXILETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
200
0093-8740_c65394df-caeb-4d3d-b01c-bc30a492c9ca
Mexiletine Hydrochloride
DRUG FOR FURTHER PROCESSING
0093-8741
Teva Pharmaceuticals USA, Inc.
20230330
MEXILETINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
250
0093-8741_c65394df-caeb-4d3d-b01c-bc30a492c9ca
orforglipron
DRUG FOR FURTHER PROCESSING
0110-0248
Lilly del Caribe, Inc.
20251106
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
1
0110-0248_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
Insulin lispro
BULK INGREDIENT
0110-0541
Lilly del Caribe, Inc.
20161017
INSULIN LISPRO
BULK INGREDIENT
1
0110-0541_f95045de-9057-4d71-bd0c-3d66df1cd2b9
Insulin lispro
BULK INGREDIENT
0110-0571
Lilly del Caribe, Inc.
20190321
INSULIN LISPRO
BULK INGREDIENT
1
0110-0571_18adf071-994e-489e-bee4-55e6b3d6a431
orforglipron
DRUG FOR FURTHER PROCESSING
0110-0700
Lilly del Caribe, Inc.
20251125
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
3
0110-0700_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
orforglipron
DRUG FOR FURTHER PROCESSING
0110-1080
Lilly del Caribe, Inc.
20251120
ORFORGLIPRON CALCIUM
DRUG FOR FURTHER PROCESSING
6
0110-1080_f2d80f03-bd49-4c2c-8064-9044d0c75dd0
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3